Drug Shortage Report for SPRYCEL
Report ID | 69624 |
Drug Identification Number | 02360829 |
Brand name | SPRYCEL |
Common or Proper name | Dasatanib 140mg |
Company Name | BRISTOL-MYERS SQUIBB CANADA |
Market Status | MARKETED |
Active Ingredient(s) | DASATINIB |
Strength(s) | 140MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 1 BTL x 30 |
ATC code | L01XE |
ATC description | OTHER ANTINEOPLASTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-01-21 |
Actual start date | 2019-01-21 |
Estimated end date | 2019-01-21 |
Actual end date | 2019-01-21 |
Shortage status | Resolved |
Updated date | 2019-01-22 |
Company comments | Orders are being monitored / allocated. No other strengths are impacted. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2344 BOUL. ALFRED-NOBEL, SUITE 300 ST-LAURENT, QUEBEC CANADA H4S 0A4 |
Company contact information | For more information please contact the Customer Service Desk at 1-800-267-0005 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v14 | 2019-01-22 | English | Compare |
v13 | 2019-01-18 | French | Compare |
v12 | 2019-01-18 | English | Compare |
v11 | 2019-01-18 | English | Compare |
v10 | 2019-01-18 | English | Compare |
v9 | 2019-01-11 | French | Compare |
v8 | 2019-01-11 | English | Compare |
v7 | 2019-01-10 | French | Compare |
v6 | 2019-01-10 | English | Compare |
v5 | 2019-01-05 | French | Compare |
v4 | 2019-01-05 | English | Compare |
v3 | 2019-01-05 | English | Compare |
v2 | 2018-12-14 | French | Compare |
v1 | 2018-12-14 | English | Compare |
Showing 1 to 14 of 14